Resilience and extensively drug-resistant tuberculosis: the unlikely ally

Int J Tuberc Lung Dis. 2017 Jun 1;21(6):713-716. doi: 10.5588/ijtld.16.0954.

Abstract

Despite recent advances and well-known treatment options, cure rates for resistant tuberculosis (TB) cases remain extraordinarily low. We present in first person the case of a patient who suffered from TB for over 7 years, and travelled to four countries in search of a cure. This experience shows how resistance patterns worsen under poor programme conditions and illustrates many of the obstacles faced by patients to obtain appropriate care: late diagnosis, lack of experienced care capacity and drug availability, and absence of psychosocial support during toxic and lengthy regimens. In addition to new tools, patient-centred systems are needed to tackle the drug-resistant TB epidemic.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antitubercular Agents / pharmacology
  • Antitubercular Agents / supply & distribution
  • Antitubercular Agents / therapeutic use*
  • Delayed Diagnosis
  • Extensively Drug-Resistant Tuberculosis / diagnosis
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Extensively Drug-Resistant Tuberculosis / microbiology
  • Humans
  • Male
  • Patient-Centered Care
  • Social Support*
  • Travel

Substances

  • Antitubercular Agents